Pereira et al. evaluated multiple HER2-positive tumor cell lines, spanning gastric (N87, KATOIII), bladder (HT1197, UMUC14, UMUC3), breast (MDAMB231, MCF7, BT474, SKBR3), pancreatic (BxPc3, MiaPaCa, Suit2), and prostate (LnCap, Pc3) cancers [191]. The gene discussed is ERBB2; the disease is neoplasm.